TickerFactsScreenerDevelopers

Pelthos Therapeutics Inc. (PTHS) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2022: -$1.57M2023: -$981.0K2024: -$5.79M2025: -$22.59M-$22.59M
2022Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$22.59M-290.0%
2024-$5.79M-490.4%
2023-$981.0K+37.4%
2022-$1.57M—